Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Malmstrom, Sarah E."'
Autor:
Ye, Xiang-Yang, Morales, Christian L., Wang, Ying, Rossi, Karen A., Malmstrom, Sarah E., Abousleiman, Mojgan, Sereda, Larisa, Apedo, Atsu, Robl, Jeffrey A., Miller, Keith J., Krupinski, John, Wacker, Dean A.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1 June 2014 24(11):2539-2545
Autor:
Zhao, Guohua, Kwon, Chet, Bisaha, Sharon N., Stein, Philip D., Rossi, Karen A., Cao, Xueying, Ung, Thao, Wu, Ginger, Hung, Chen-Pin, Malmstrom, Sarah E., Zhang, Ge, Qu, Qinling, Gan, Jinping, Keim, William J., Cullen, Mary Jane, Rohrbach, Kenneth W., Devenny, James, Pelleymounter, Mary Ann, Miller, Keith J., Robl, Jeffrey A.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1 July 2013 23(13):3914-3919
Autor:
Fevig, John M., Feng, Jianxin, Rossi, Karen A., Miller, Keith J., Wu, Ginger, Hung, Chen-Pin, Ung, Thao, Malmstrom, Sarah E., Zhang, Ge, Keim, William J., Cullen, Mary Jane, Rohrbach, Kenneth W., Qu, Qinling, Gan, Jinping, Pelleymounter, Mary Ann, Robl, Jeffrey A.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1 January 2013 23(1):330-335
Autor:
Carpenter, Joseph, Ying Wang, Gang Wu, Jianxin Feng, Xiang-Yang Ye, Morales, Christian L., Broekema, Matthias, Rossi, Karen A., Miller, Keith J., Murphy, Brian J., Ginger Wu, Malmstrom, Sarah E., Azzara, Anthony V., Sher, Philip M., Fevig, John M., Alt, Andrew, Bertekap, Robert L., Cullen, Mary Jane, Harper, Timothy M., Foster, Kimberly
Publikováno v:
Journal of Medicinal Chemistry; 7/27/2017, Vol. 60 Issue 14, p6166-6190, 25p
Autor:
Wacker, Dean A., Wang, Ying, Broekema, Matthias, Rossi, Karen, O’Connor, Steven, Hong, Zhenqiu, Wu, Ginger, Malmstrom, Sarah E., Hung, Chen-Pin, LaMarre, Linda, Chimalakonda, Anjaneya, Zhang, Lisa, Xin, Li, Cai, Hong, Chu, Cuixia, Boehm, Stephanie, Zalaznick, Jacob, Ponticiello, Randolph, Sereda, Larisa, Han, Song-Ping
Publikováno v:
Journal of Medicinal Chemistry; Sep2014, Vol. 57 Issue 18, p7499-7508, 10p
Synthesis and SAR of potent and selective tetrahydropyrazinoisoquinolinone 5-HT2C receptor agonists.
Autor:
Zhao, Guohua1 guohua.zhao@bms.com, Kwon, Chet1, Bisaha, Sharon N.1, Stein, Philip D.1, Rossi, Karen A.1, Cao, Xueying1, Ung, Thao1, Wu, Ginger1, Hung, Chen-Pin1, Malmstrom, Sarah E.1, Zhang, Ge1, Qu, Qinling1, Gan, Jinping1, Keim, William J.1, Cullen, Mary Jane1, Rohrbach, Kenneth W.1, Devenny, James1, Pelleymounter, Mary Ann1, Miller, Keith J.1, Robl, Jeffrey A.1
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. Jul2013, Vol. 23 Issue 13, p3914-3919. 6p.
Autor:
Fevig, John M. john.fevig@bms.com, Feng, Jianxin1, Rossi, Karen A.1, Miller, Keith J.1, Wu, Ginger1, Hung, Chen-Pin1, Ung, Thao1, Malmstrom, Sarah E.1, Zhang, Ge1, Keim, William J.1, Cullen, Mary Jane1, Rohrbach, Kenneth W.1, Qu, Qinling1, Gan, Jinping1, Pelleymounter, Mary Ann1, Robl, Jeffrey A.1
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. Jan2013, Vol. 23 Issue 1, p330-335. 6p.
Autor:
Carpenter J; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Wang Y; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Wu G; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Feng J; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Ye XY; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Morales CL; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Broekema M; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Rossi KA; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Miller KJ; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Murphy BJ; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Wu G; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Malmstrom SE; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Azzara AV; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Sher PM; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Fevig JM; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Alt A; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Bertekap RL Jr; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Cullen MJ; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Harper TM; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Foster K; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Luk E; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Xiang Q; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Grubb MF; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Robl JA; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States., Wacker DA; Departments of Discovery Chemistry, Discovery Biology, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pharmaceutical Research Institute , P.O. Box 5400, Princeton, New Jersey 08543-5400, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2017 Jul 27; Vol. 60 (14), pp. 6166-6190. Date of Electronic Publication: 2017 Jul 07.
Autor:
Wacker DA; Department of Discovery Chemistry, Bristol-Myers Squibb, Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400, USA. dean.wacker@bms.com, Varnes JG, Malmstrom SE, Cao X, Hung CP, Ung T, Wu G, Zhang G, Zuvich E, Thomas MA, Keim WJ, Cullen MJ, Rohrbach KW, Qu Q, Narayanan R, Rossi K, Janovitz E, Lehman-McKeeman L, Malley MF, Devenny J, Pelleymounter MA, Miller KJ, Robl JA
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2007 Mar 22; Vol. 50 (6), pp. 1365-79. Date of Electronic Publication: 2007 Feb 23.